Join The Discussion

 

RadioShack sees stock jump on investment report

Fort Worth-based RadioShack saw its stock increase as much as 45 percent on Friday as investor Standard General LP said it was continuing talks on new financing for the electronics retailer.

read more >

Fort Worth couple gets in 'Shark Tank,' comes out with deal

A Fort Worth couple who started a business when they couldn’t sleep, were the first entrepreneurs to get a deal on ABC’s Shark Tank in the season premiere on Sept. 26.

read more >

20 from Dallas-Fort Worth on Forbes wealthiest list

There are 20 Dallas-Fort Worth residents listed among the 400 richest Americans, according to the Forbes 400 list of The Richest People in America 2014.

read more >

Internal audit says EPA mismanaged Fort Worth project

FORT WORTH, Texas (AP) — An internal audit by the U.S. Environmental Protection Agency reveals the agency mismanaged an experiment using new ways to demolish asbestos-ridden buildings.

read more >

Texas Wesleyan acquires two strip shopping centers on East Rosedale

Texas Wesleyan University has purchased two strip shopping centers on East Rosedale Street across from its Southeast Fort Worth campus, the university’s president said Friday.

read more >

Brookhaven Medical to acquire Wound Management

 

Brookhaven Medical Inc., an Atlanta-based medical device company with interests in dialysis devices and advanced wound care, said Oct. 15 it will acquire Wound Management Technologies Inc. of Fort Worth, an emerging commercial stage company focused on the worldwide advanced wound care market.


The letter of intent, which outlines the primary terms of a merger of Wound Management into Brookhaven, has been approved by the board of directors of both companies.
The transaction is expected to close in the first half of 2014.
John Feltman, chairman and CEO of Brookhaven, said, “Wound Management is an ideal match for Brookhaven’s synergistic approach to building our leading medical technology and products, and I believe it will be an integral part of our success in ushering Brookhaven into the advanced wound care industry.”


In addition to the Wound Management acquisition, Brookhaven recently entered into an agreement in principle to acquire a medical device company specializing in dialysis access and peripheral vascular applications, and also recently completed a strategic investment in CreatiVasc Medical Inc., a private company based in Greenville, S.C., which is developing a breakthrough hemoaccess valve system for dialysis grafts. Feltman said that CreatiVasc is one of only three companies recently selected by the FDA for inclusion in Brookhaven’s Innovation Pathway Program.
Brookhaven can achieve rapid growth and significant market share, according to Feltman.
“The global market segments we serve represent a market opportunity in excess of $50 billion. It is our firm belief that Wound Management and our other planned acquisitions help position Brookhaven to capture a significant share of product sales in those targeted market segments,” he said.


Wound Management recently entered into a three-year marketing and distribution agreement for CellerateRX, a patented collagen product, with WellDyne Inc., a privately-held health services company that provides pharmacy benefit management, mail order pharmacy and specialty drug fulfillment, in addition to online access to a broad range of information on health, disease, pharmaceuticals and wellness.
“By working with Brookhaven, we have the best opportunity for our CellerateRX wound care and surgical products to achieve substantial growth and to expeditiously take our emerging resorbable bone wax technology to market,” said Robert Lutz Jr., chairman and CEO of Wound Management Technologies. - Betty Dillard
 

< back

Email   email
hide
Arena
What do you think of the new plans for a new Will Rogers arena and changes at the Convention Center?